Free Trial

Hoth Therapeutics (HOTH) Short Interest Ratio & Short Volume

Hoth Therapeutics logo
$0.85 +0.02 (+2.24%)
(As of 02:21 PM ET)

Hoth Therapeutics Short Interest Data

Hoth Therapeutics (HOTH) has a short interest of 620,800 shares, representing 9.08% of the float (the number of shares available for trading by the public). This marks a 98.15% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.2, indicating that it would take 0.2 days of the average trading volume of 1.46 million shares to cover all short positions.

Current Short Interest
620,800 shares
Previous Short Interest
313,300 shares
Change Vs. Previous Month
+98.15%
Dollar Volume Sold Short
$527,680.00
Short Interest Ratio
0.2 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
6,900,000 shares
Float Size
6,840,000 shares
Short Percent of Float
9.08%
Today's Trading Volume
877,036 shares
Average Trading Volume
1,461,806 shares
Today's Volume Vs. Average
60%
Short Selling Hoth Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Hoth Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

HOTH Short Interest Over Time

HOTH Days to Cover Over Time

HOTH Percentage of Float Shorted Over Time

Hoth Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/2024620,800 shares $527,680.00 +98.2%9.1%0.2 $0.85
10/15/2024313,300 shares $277,740.45 No Change4.6%0.1 $0.89
9/30/2024313,300 shares $275,704.00 +27.7%4.6%0.1 $0.88
9/15/2024245,300 shares $269,830.00 +11.8%3.6%0.1 $1.10
8/31/2024219,400 shares $152,241.66 +3.3%3.2%0.1 $0.69
8/15/2024212,500 shares $131,176.25 -39.8%3.1%0.3 $0.62
7/31/2024352,700 shares $242,375.44 +521.0%6.6%0.5 $0.69
7/15/202456,800 shares $49,984.00 -25.4%1.1%0.1 $0.88
6/30/202476,100 shares $69,197.73 -27.4%1.4%1 $0.91
6/15/2024104,800 shares $100,608.00 +95.5%2.0%0.8 $0.96
5/31/202453,600 shares $62,712.00 -39.5%1.1%0.1 $1.17
5/15/202488,600 shares $105,434.00 -32.5%1.8%0.2 $1.19
4/30/2024131,300 shares $160,186.00 -10.4%2.7%0.3 $1.22
4/15/2024146,600 shares $174,454.00 -32.8%3.4%0.3 $1.19
3/31/2024218,100 shares $331,512.00 +698.9%5.0%0.5 $1.52
3/15/202427,300 shares $31,668.00 -64.3%0.6%0.1 $1.16
2/29/202476,400 shares $93,972.00 -9.9%1.8%0.4 $1.23
2/15/202484,800 shares $119,568.00 -25.2%2.0%0.3 $1.41
1/31/2024113,400 shares $156,492.00 -15.3%2.6%0.4 $1.38
1/15/2024133,800 shares $176,616.00 -55.5%3.1%0.5 $1.32
12/31/2023300,600 shares $432,864.00 +161.4%7.0%1.3 $1.44
12/15/2023115,000 shares $138,000.00 +103.9%2.7%0.5 $1.20
11/30/202356,400 shares $63,168.00 +89.9%1.3%0.2 $1.12
11/15/202329,700 shares $30,591.00 +19.8%0.7%0.1 $1.03
10/31/202324,800 shares $30,256.00 -69.6%0.8%0.1 $1.22
10/15/202381,500 shares $112,470.00 -19.9%2.5%0.4 $1.38
9/30/2023101,700 shares $154,614.51 -64.1%3.1%0.4 $1.52
9/15/2023283,100 shares $520,904.00 +146.8%8.7%1.2 $1.84
8/31/2023114,700 shares $248,899.00 -30.7%3.5%0.8 $2.17
8/15/2023165,600 shares $423,936.00 +59.4%5.1%0.1 $2.56
7/31/2023103,900 shares $271,179.00 -7.0%3.2%0.1 $2.61
7/15/2023111,700 shares $309,409.00 -40.9%3.4%0.1 $2.77
6/30/2023189,100 shares $567,300.00 -43.5%5.8%0.1 $3.00
6/15/2023334,600 shares $1.04 million +322.5%10.3%0.2 $3.11
5/31/202379,200 shares $125,928.00 +96.5%2.4%0 $1.59
5/15/202340,300 shares $64,278.50 No Change1.2%0.1 $1.60
10/31/20228,600 shares $48,160.00 -78.2%0.7%0.2 $5.60
10/15/202239,500 shares $322,517.50 -44.9%N/A0.1 $8.17
9/30/202271,700 shares $24,944.43 -39.7%N/A0.1 $0.35
9/15/2022118,900 shares $48,475.53 -26.5%N/A0.2 $0.41
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

8/31/2022161,800 shares $69,574.00 +153.2%N/A0.2 $0.43
8/15/202263,900 shares $29,630.43 -54.5%N/A0.1 $0.46
7/31/2022140,300 shares $57,242.40 -60.0%N/A0.2 $0.41
7/15/2022350,900 shares $140,360.00 -32.7%N/A0.4 $0.40
6/30/2022521,300 shares $218,424.70 +349.4%N/A0.1 $0.42
6/15/2022116,000 shares $49,300.00 +98.3%N/A0 $0.43
5/31/202258,500 shares $25,564.50 -81.2%N/A0 $0.44
5/15/2022311,100 shares $149,016.90 -23.4%N/A0.1 $0.48
4/30/2022405,900 shares $212,448.06 -74.5%N/A0.1 $0.52
4/15/20221,590,000 shares $1.10 million +382.1%N/A0.4 $0.69
3/31/2022329,800 shares $228,221.60 -13.4%N/A0.1 $0.69
3/15/2022380,700 shares $206,948.52 +404.2%1.7%0.1 $0.54
2/28/202275,500 shares $43,035.00 -14.1%0.3%0 $0.57
2/15/202287,900 shares $53,935.44 -17.2%0.4%0 $0.61
1/31/2022106,100 shares $60,137.48 -82.9%0.5%0 $0.57
1/15/2022620,000 shares $502,200.00 +224.3%N/A0.1 $0.81
12/31/2021191,200 shares $126,172.69 +2.7%1.0%0 $0.66
12/15/2021186,100 shares $133,619.80 +16.5%0.9%0.7 $0.72
11/30/2021159,700 shares $130,794.30 -32.5%0.9%0.6 $0.82
11/15/2021236,400 shares $241,128.00 +34.2%1.3%0.7 $1.02
10/29/2021176,100 shares $188,427.00 -14.9%1.0%0.4 $1.07
10/15/2021206,800 shares $239,888.00 +104.8%1.1%0.5 $1.16
9/30/2021101,000 shares $120,190.00 +2.9%0.5%0.2 $1.19
9/15/202198,200 shares $122,750.00 -74.6%0.5%0.2 $1.25
8/31/2021386,000 shares $524,960.00 -50.8%2.1%0.7 $1.36
8/13/2021785,100 shares $1.00 million +497.5%4.2%0.8 $1.28
7/30/2021131,400 shares $169,506.00 -11.8%0.7%0.1 $1.29
7/15/2021149,000 shares $210,090.00 -14.9%0.8%0.1 $1.41
6/30/2021175,100 shares $280,160.00 -6.6%0.9%0.1 $1.60
6/15/2021187,400 shares $294,218.00 +183.1%1.0%0.1 $1.57
5/28/202166,200 shares $95,990.00 -62.2%0.4%0 $1.45
5/14/2021174,900 shares $229,119.00 +267.4%N/A0 $1.31
4/30/202147,600 shares $70,924.00 -94.7%N/A0 $1.49
4/15/2021896,100 shares $1.48 million -42.2%N/A0 $1.65
3/31/20211,550,000 shares $2.93 million +39.6%N/A0.4 $1.89
3/15/20211,110,000 shares $2.39 million +182.6%15.5%0.2 $2.15
2/26/2021392,800 shares $911,296.00 +1.4%5.5%0.1 $2.32
2/12/2021387,300 shares $968,250.00 -16.0%5.4%0.1 $2.50
1/29/2021461,000 shares $1.01 million -49.9%7.3%0.2 $2.19
1/15/2021919,700 shares $2.07 million +2,597.1%12.9%0.4 $2.25
12/31/202034,100 shares $55,924.00 +42.7%0.4%0 $1.64
12/15/202023,900 shares $40,869.00 +102.5%0.3%0.1 $1.71
11/30/202011,800 shares $19,942.00 -6.4%0.1%0.1 $1.69
11/15/202012,600 shares $21,924.00 -35.7%0.1%0.1 $1.74
10/30/202019,600 shares $34,300.00 -41.8%0.2%0.1 $1.75
10/15/202033,700 shares $62,682.00 +21.7%0.4%0.1 $1.86
9/30/202027,700 shares $54,569.00 -40.7%0.3%0 $1.97
9/15/202046,700 shares $105,075.00 -36.7%0.5%0.1 $2.25
8/31/202073,800 shares $195,570.00 -39.3%0.8%0.1 $2.65
8/14/2020121,600 shares $327,104.00 +185.5%1.4%0.1 $2.69
Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)

It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…

7/31/202042,600 shares $116,298.00 -44.0%0.5%0 $2.73
7/15/202076,000 shares $199,120.00 -71.3%0.9%0.1 $2.62
6/30/2020265,200 shares $670,956.00 -14.4%3.3%0.5 $2.53
6/15/2020309,700 shares $839,287.00 -8.6%3.9%0.7 $2.71
5/29/2020338,700 shares $961,908.00 +1,701.6%4.2%0.6 $2.84
5/15/202018,800 shares $71,440.00 +44.6%0.3%0 $3.80
4/30/202013,000 shares $46,150.00 -7.8%0.2%0 $3.55
4/15/202014,100 shares $43,992.00 -66.4%0.2%0.1 $3.12
3/31/202042,000 shares $143,220.00 +307.8%0.7%0.2 $3.41
3/13/202010,300 shares $32,239.00 +43.1%0.2%0.7 $3.13
2/28/20207,200 shares $26,928.00 -71.8%0.2%0.2 $3.74
2/14/202025,500 shares $102,255.00 +99.2%0.6%0.5 $4.01
1/31/202012,800 shares $55,680.00 -33.7%0.3%0.4 $4.35
1/15/202019,300 shares $95,728.00 -49.6%0.4%0.7 $4.96
12/31/201938,300 shares $186,138.00 -11.3%0.9%1.5 $4.86

HOTH Short Interest - Frequently Asked Questions

What is Hoth Therapeutics' current short interest?

Short interest is the volume of Hoth Therapeutics shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 620,800 shares of HOTH short. 9.08% of Hoth Therapeutics' shares are currently sold short. Learn More on Hoth Therapeutics' current short interest.

What is a good short interest percentage for Hoth Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 9.08% of Hoth Therapeutics' floating shares are currently sold short.

Is Hoth Therapeutics' short interest increasing or decreasing?

Hoth Therapeutics saw a increase in short interest in October. As of October 31st, there was short interest totaling 620,800 shares, an increase of 98.1% from the previous total of 313,300 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Hoth Therapeutics' float size?

Hoth Therapeutics currently has issued a total of 6,900,000 shares. Some of Hoth Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Hoth Therapeutics currently has a public float of 6,840,000 shares.

How does Hoth Therapeutics' short interest compare to its competitors?

9.08% of Hoth Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Hoth Therapeutics: Tempest Therapeutics, Inc. (11.82%), GlycoMimetics, Inc. (8.75%), Pieris Pharmaceuticals, Inc. (1.70%), Cocrystal Pharma, Inc. (0.03%), MIRA Pharmaceuticals, Inc. (12.65%), Enlivex Therapeutics Ltd. (0.75%), Pulmatrix, Inc. (0.19%), Cyclo Therapeutics, Inc. (0.69%), Spruce Biosciences, Inc. (0.56%), Forte Biosciences, Inc. (0.08%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Hoth Therapeutics stock?

Short selling HOTH is an investing strategy that aims to generate trading profit from Hoth Therapeutics as its price is falling. HOTH shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Hoth Therapeutics?

A short squeeze for Hoth Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HOTH, which in turn drives the price of the stock up even further.

How often is Hoth Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HOTH, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:HOTH) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners